|
Mutation Information
|
Mutation Site
|
M552V |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
P |
|
Relevant Drug
|
lamivudine (LAM);emtricitabine (FTC) |
Literature Information
|
PubMed PMID
|
11312349
|
|
Published Year
|
2001 |
|
Journal
|
Journal of virology |
|
Title
|
Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC). |
|
Author
|
Das K,Xiong X,Yang H,Westland CE,Gibbs CS,Sarafianos SG,Arnold E |
|
Evidence
|
The predominant lamivudine resistance mutations in HBV-infected patients are Met552IIe and Met552Val (Met552Ile/Val), frequently in association with a second mutation, Leu528Met.
|
|
|